Form 4: Quest Diagnostics Director Acquires Additional Shares Through Dividend Reinvestment
SEC Form 4
Director Vicky B. Gregg increased her holdings in Quest Diagnostics through a dividend reinvestment plan.
Summary
- On October 21, 2024, Vicky B. Gregg, a director of Quest Diagnostics Inc., acquired 76 shares of common stock at a price of $149.371 per share.
- The acquisition was made through a dividend reinvestment plan.
- Following the transaction, Gregg directly owns 18,045 shares of Quest Diagnostics Inc.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects a director increasing their stake in the company through a standard dividend reinvestment plan, indicating confidence in the company's performance.
Positives
- The director's participation in the dividend reinvestment plan signals confidence in the company's future.
Industry Context
Directors acquiring shares through dividend reinvestment plans is a common practice and generally viewed positively by investors.
Stakeholder Impact
- The transaction could have a slightly positive impact on shareholders as it signals confidence from a company director.
Key Dates
| Date | Description |
|---|---|
| 10/21/2024 | Date of transaction: Vicky B. Gregg acquired 76 shares of common stock through a dividend reinvestment plan. |
| 10/25/2024 | Date of signature: Sean D. Mersten, Attorney in Fact, signed the Form 4 on behalf of Vicky B. Gregg. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.